Related Experiment Video
Updated: Feb 24, 2026
Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE
Published on: April 21, 2019
Evaluation of the Elecsys syphilis immunoassay for routine screening of serum samples in China
Chuanmin Tao1, Xiaoke Hao2, Wei Xu3
1Department of Laboratory Medicine, West China Hospital, Sichuan University, No. 37 Guoxuexiang, Chengdu, 610041, China.
Insights
The Elecsys immunoassay demonstrates superior performance for syphilis diagnosis, showing 100% sensitivity and high specificity in detecting Treponema pallidum antibodies. This automated assay is ideal for routine syphilis screening in clinical laboratories.
Area of Science:
- Clinical diagnostics
- Immunology
- Microbiology
Background:
- Syphilis diagnosis relies on accurate detection of Treponema pallidum antibodies.
- Current immunoassays vary in sensitivity and specificity, impacting diagnostic reliability.
- Evaluating new diagnostic tools is crucial for effective syphilis management.
Purpose of the Study:
- To compare the performance of the Roche Diagnostics Elecsys immunoassay against other commonly used assays for Treponema pallidum antibody detection.
- To assess the sensitivity, specificity, and accuracy of the Elecsys assay in a large cohort of Chinese serum samples.
Main Methods:
- A comparative study involving 13,767 serum samples from 13 laboratories across China.
- Testing included 999 confirmed syphilis cases and 158 borderline samples.
- Performance evaluation against Abbott Architect, InTec, and KHB immunoassays, with Mikrogen Syphilis Immunoblot as a confirmatory method.
Main Results:
- The Elecsys immunoassay achieved 100% sensitivity and 99.81% specificity.
- Compared to Architect, InTec, and KHB assays, Elecsys showed higher sensitivity (100% vs. 98.26-99.11%) and comparable specificity (99.81% vs. 99.74-99.93%).
- Elecsys demonstrated fewer false positives and no false negatives in borderline samples.
Conclusions:
- The Elecsys immunoassay is a highly sensitive and specific assay for Treponema pallidum antibody detection.
- Its automation, speed, and throughput capacity make it superior for routine syphilis screening.
- This assay offers improved accuracy for syphilis diagnosis in clinical settings.
Abstract:
We compared the performance of the Roche Diagnostics Elecsys immunoassay for the detection of Treponema pallidum specific antibodies in patient serum samples with that of the Abbott Laboratories Architect chemiluminescent microparticle immunoassay and the InTec and KHB enzyme-linked immunosorbent assays, which are commonly used in China. We tested 13,767 serum samples collected from 13 independent laboratories throughout China, which included samples from 999 previously confirmed syphilis cases and 158 'borderline' samples previously identified using the Architect, InTec, and KHB tests. The Mikrogen Syphilis Immunoblot was used to confirm positive test results. The consistency between the four different assays was 100%. The sensitivity of Elecsys immunoassay was 100% versus 98.26% for Architect, 99.11% for InTec; and 98.56% for KHB. The specificity of the Elecsys immunoassay was 99.81% versus 99.74% for Architect; 99.93% versus 99.80% for InTec; and 99.85% versus 99.77% for KHB. For borderline samples, the Elecsys immunoassay yielded no false-negative results and fewer false-positive results, compared to the other tests. Considering the ease-of-use, automation, high speed, and high throughput capacity of the Elecsys assay, the higher sensitivity and specificity indicate it is superior for routine screening of serum samples for syphilis diagnosis.
